Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Crohn's Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03464136
What this trial is testing

Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year

Who this might be right for
Crohn Disease
Janssen Scientific Affairs, LLC 386
Post-approval studies (Phase 4)Looking for participantsNCT05928039
What this trial is testing

PATHFINDER: Evaluating the Optimal First-Line Treatment Strategy for Moderate-to-Severely Active Ileal-dominant Crohn's Disease

Who this might be right for
Crohn Disease
University of Calgary 297
Testing effectiveness (Phase 2)Active Not RecruitingNCT05242471
What this trial is testing

Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Janssen Research & Development, LLC 703
Large-scale testing (Phase 3)Looking for participantsNCT05923073
What this trial is testing

Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Janssen Research & Development, LLC 120
Post-approval studies (Phase 4)Looking for participantsNCT06045754
What this trial is testing

Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Who this might be right for
Crohn's Disease
Takeda 50
Not applicableAvailableNCT06856135
What this trial is testing

Expanded Access to Vedolizumab for Children and Teenagers With Ulcerative Colitis or Crohn's Disease in the USA

Who this might be right for
Crohn's DiseaseUlcerative Colitis
Takeda
Not applicableStudy completedNCT02538679
What this trial is testing

A Comparison of Ultrasound Guided Transversus Abdominis Plane Nerve Block Techniques

Who this might be right for
Crohn's DiseaseInflammatory Bowel DiseasePostoperative Pain
Cedars-Sinai Medical Center 127
Not applicableUnknownNCT06324591
What this trial is testing

Observational Prospective Study to Identify Intestinal Microbial Profiles in Newly Diagnosed Crohn's Disease Patients

Who this might be right for
Crohn Disease
Meyer Children's Hospital IRCCS 30
Large-scale testing (Phase 3)Study completedNCT03104413
What this trial is testing

Assess the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment

Who this might be right for
Crohn's Disease
AbbVie 618
Early research (Phase 1)WithdrawnNCT03414788
What this trial is testing

Distribution of a Single IV Dose Of [124I]-Pf 06687234 and Pf 06687234 Assessed With PET-CT Imaging In Moderate To Severe Ulcerative Colitis and Crohn's Disease

Who this might be right for
Inflammatory Bowel Disease
Pfizer
Large-scale testing (Phase 3)Study completedNCT01233960
What this trial is testing

Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's Disease

Who this might be right for
Crohn's Disease
Mesoblast, Inc. 73
Not applicableStudy completedNCT04151420
What this trial is testing

Real Life Remote Monitoring of Mild, Moderate and Severe Infectious Complications in IBD by Patient Reported Assessment

Who this might be right for
Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis+3 more
Maastricht University Medical Center 584
Large-scale testing (Phase 3)Study completedNCT03440385
What this trial is testing

Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Celgene 606
Testing effectiveness (Phase 2)Ended earlyNCT04102111
What this trial is testing

A Study Evaluating Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Janssen Research & Development, LLC 48
Large-scale testing (Phase 3)Ended earlyNCT03464097
What this trial is testing

A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Celgene 550
Not applicableUnknownNCT05635266
What this trial is testing

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

Who this might be right for
Age-Related Macular DegenerationAllergiesAlpha-Gal Syndrome+44 more
Sanguine Biosciences 20,000
Large-scale testing (Phase 3)Study completedNCT02065570
What this trial is testing

Study to Evaluate Efficacy and Safety of Two Drug Regimens in Subjects With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
AbbVie 514
Testing effectiveness (Phase 2)Ended earlyNCT00562887
What this trial is testing

Dose Ranging Study Comparing the Efficacy, Safety and Pharmacokinetics of Intravenous Infusions of ABT-874 vs Placebo in Subjects With Active Crohn's Disease

Who this might be right for
Crohn's Disease
Abbott 246
Testing effectiveness (Phase 2)Study completedNCT01203631
What this trial is testing

Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease

Who this might be right for
InflammationCrohn's Disease
Janssen Research & Development, LLC 78
Post-approval studies (Phase 4)Study completedNCT05029921
What this trial is testing

Ustekinumab (STELARA) in Chinese Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Janssen Research & Development, LLC 182
Next Page